In conclusion, EPO can regulate the oxidative stress in hippocampal neurons, thereby resisting apoptosis and inhibiting inflammatory response through the BDNF/TrKB/PI3K/ERK1/2 axis to effectively ameliorate the cognitive dysfunction caused by chronic hypoperfusion in VD rats, which provides a new therapeutic target for VD. This evidence concerns the gene MAPK3 and sexually transmitted disease.